Cardiology Online - International Academy of Cardiology
»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Discussion Groups
   Job Opportunities
   Contact Us





18th World Congress on Heart Disease



Saul Schaefer, M.D., University of California, Davis, CA, USA


While physicians generally treat cardiovascular disease and risk factors with conventional medications such as statins and beta blockers, patients often use complementary or integrative therapy such as fish oil, vitamins, enzymes, and chelation therapy. This $45 billion industry is based on the belief that non-allopathic therapies can lower cardiovascular risk in addition to, or in lieu of, conventional therapy. The NIH Center for Complementary and Alternative Medicine supports therapy "for which there is some high-quality scientific evidence of safety and effectiveness"; however, most integrative therapies do not meet this test. Prospective studies support a minor role for omega3 fatty acids, a Mediterranean diet, and possibly vitamin C supplementation to reduce cardiovascular risk in selected individuals. No evidence to data supports the routine use of multi-vitamins, coenzyme Q, vitamin D or chelation therapy. The critical role of addressing conventional risk factors should not be abridged by unproven integrative therapies.



©1998-2014 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.